A Leading Multinational Biopharmaceutical Company Chooses Bioscrypt 3D Facial Recognition Solution to Secure its New International Administration and Production Centers

TORONTO, — Bioscrypt Inc., a leading provider of enterprise access control technology, today announced a leading multinational integrated biopharmaceutical company and one of the fastest growing pharmaceutical companies on NASDAQ, has chosen Bioscrypt’s VisionAccess 3D facial recognition technology to secure access to its facilities and white rooms, where it produces pharmaceuticals.

Bioscrypt’s 3D facial recognition biometric technology both enhances and simplifies the Company’s access control processes, allowing it to increase security as well as ease of use for employees. VisionAccess allows employees to enter facilities using their face as the sole identification factor. This eliminates the need for badges, which are not allowed in production or white rooms where employees cannot bring any foreign objects. Bioscrypt’s solution also enabled the Company to better meet regulatory requirements for securing white rooms.

“With the strong regulations in our business, we have looked at various solutions to secure our new administration and production site ranging from Smart Cards, PIN codes and fingerprint biometrics but 3D face recognition from Bioscrypt was clearly the best solution in the market to secure a pharmaceutical production site,” said the Project Director at the Company. “3D face provides the high level of security required to secure access to white rooms where drugs are produced. The solution is extremely quick, elegant and above all it does not require a badge as no products are allowed inside white rooms. Our employees have their face as the sole identifier to enter the building and access the white rooms!”

The company deployed 10 Bioscrypt VisionAccess 3D Face Readers at control points inside its building as well as additional face readers at the main entrances at its new administration and production site in Switzerland. As employees walk up to a door, they pause for less than a second in front of a reader which confirms their identity against a database, allowing their 3D facial patterns to be their single identifier.

“We are pleased to provide the Company with a means for securing their labs in a way that meets the unique requirements of the pharmaceuticals industry,” said Robert M. Douglas, President and CEO of Bioscrypt. “Our distinctive 3D physical access control reader, VisionAccess, was able to help the biopharmaceutical company eliminate the need for badge management.”

About Bioscrypt Inc.

Bioscrypt is an enterprise access control solution provider, enabling the unification of physical and logical access with its Door to Desktop® products. Bioscrypt’s hardware and software solutions deliver strong authentication processes to facilities, equipment, IT networks and computer applications and allow organizations to administer unified identities across the enterprise.

Building on its proven expertise in biometric technology and its unique multi-factor authentication platform, Bioscrypt integrates all major secure authentication standards, transforming how organizations are bridging the gap between physical and logical access to create secure working environments. More information is available at http://www.bioscrypt.com.